Trial Profile
The pharmacokinetics of lopinavir/ritonavir in combination with atazanavir in HIV-infected subjects
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 21 Mar 2013
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Atazanavir
- Indications HIV infections
- Focus Pharmacokinetics
- 23 Apr 2008 The expected completion date for this trial is now 1 Jun 2008.
- 23 Apr 2008 Status changed from recuiting to suspended.
- 08 Feb 2007 New trial record.